Jerome Cambre - 17 Jan 2024 Form 4 Insider Report for VIEMED HEALTHCARE, INC. (VMD)

Role: Vice President of Sales
Signature: /s/ Jesse Bergeron, Attorney-in-Fact
Issuer symbol: VMD
Transactions as of: 17 Jan 2024
Net transactions value: -$61,097
Form type: 4
Filing time: 19 Jan 2024, 17:50:11 UTC
Previous filing: 11 May 2023
Next filing: 22 Jan 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VMD	Common Shares	Options Exercise		+2,131	+3.2%		68,011	17 Jan 2024	Direct	F1
transaction	VMD	Common Shares	Disposed to Issuer	$15,748	-2,131	-3.1%	$7.39	65,880	17 Jan 2024	Direct	F2
transaction	VMD	Common Shares	Options Exercise		+8,525	+13%		74,405	17 Jan 2024	Direct	F3
transaction	VMD	Common Shares	Tax liability	$22,466	-3,040	-4.1%	$7.39	71,365	17 Jan 2024	Direct	F2, F4
transaction	VMD	Common Shares	Options Exercise		+3,003	+4.2%		74,368	18 Jan 2024	Direct	F1
transaction	VMD	Common Shares	Disposed to Issuer	$22,883	-3,003	-4%	$7.62	71,365	18 Jan 2024	Direct	F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VMD	Phantom Share Units	Options Exercise		-2,131	-33%		4,263	17 Jan 2024	Common Shares	2,131		Direct	F1, F6
transaction	VMD	Restricted Stock Units	Options Exercise	$0	-8,525	-33%	$0.000000	17,050	17 Jan 2024	Common Shares	8,525		Direct	F3, F7
transaction	VMD	Phantom Share Units	Options Exercise		-3,003	-50%		3,003	18 Jan 2024	Common Shares	3,003		Direct	F1, F8

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents vesting of cash-settled phantom shares granted under the Issuer's Phantom Share Unit Plan. Each phantom share is the economic equivalent of one Company common share. The settlement of the phantom shares for cash is reported on this Form 4 as a disposition of the phantom shares being settled in exchange for the acquisition of the underlying Company common shares, and a simultaneous disposition of the underlying Company common shares to the Company for cash.
F2	Per share value is based on the market closing price of the common shares for January 17, 2024.
F3	Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share.
F4	Shares that were withheld by the issuer to satisfy the reporting person's tax obligation resulting from the vesting of restricted stock units.
F5	Per share value is based on the market closing price of the common shares for January 18, 2024.
F6	Represents an award granted on January 17, 2023 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date.
F7	Restricted Stock Units (RSUs) granted to reporting person on January 17, 2023, which vest in three equal annual installments beginning on the first anniversary of the grant date.
F8	Represents an award granted on January 18, 2022 under the Issuer's Phantom Share Unit Plan which vests in three equal annual installments beginning on the first anniversary of the grant date.